ALYATEC evaluates the effect of pharmaceutical treatments in development or already on the market, as well as medical devices and alternative solutions such as air purifiers, acaricide products or respiratory protection masks. All clinical studies performed by ALYATEC are in compliance with Good Clinical Practice (GCP).
We offer all services related to clinical studies in order to test solutions against respiratory allergies:
- Design of clinical trial protocols according to your objectives related to asthma, rhinitis and conjunctivitis
- Investigational site within multicentric clinical studies dealing with allergy
- Phase 1 to 4 clinical studies: proof of concept, post-market, onset and mechanism of action, dose-escalation
- Real-world studies (RWE/RWD)
- Submission to health regulatory authorities and ethical committees
- Patients’ enrollment thanks to our large database of allergic patients
- Conduction of clinical trials including ALYATEC allergen exposure chamber or natural conditions (in-field) or both (hybrid studies) including up to 200 patients
- Biological samples collection for specific biomarkers analyses
- Clinical data management and statistics
- Clinical report writing
- Writing and submission of scientific publications
- Allergen dosing
- Scientific and medical consulting
Feel free to contact us in order to set up a tailor-made clinical project that perfectly meets your development requirements.
